16,826 Shares in Stryker Corporation $SYK Acquired by Hohimer Wealth Management LLC

Posted by Brenda Bartman on Nov 9th, 2026

Hohimer Wealth Management LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 16,826 shares of the medical technology company’s stock, valued at approximately $4,634,000.

Several other hedge funds also recently bought and sold shares of the company. Community Bank & Trust Waco Texas increased its holdings in Stryker by 2.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 1,395 shares of the medical technology company’s stock worth $439,000 after acquiring an additional 31 shares during the period. Cornerstone Financial Management LLC lifted its stake in Stryker by 66.0% in the 2nd quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock worth $25,000 after purchasing an additional 31 shares in the last quarter. NWF Advisory Services Inc. boosted its holdings in Stryker by 2.3% in the 2nd quarter. NWF Advisory Services Inc. now owns 1,472 shares of the medical technology company’s stock valued at $463,000 after purchasing an additional 33 shares during the period. Private Harbour Investment Management & Counsel LLC boosted its holdings in Stryker by 0.9% in the 2nd quarter. Private Harbour Investment Management & Counsel LLC now owns 3,927 shares of the medical technology company’s stock valued at $1,236,000 after purchasing an additional 34 shares during the period. Finally, Natural Investments LLC boosted its holdings in Stryker by 1.2% in the 2nd quarter. Natural Investments LLC now owns 2,789 shares of the medical technology company’s stock valued at $878,000 after purchasing an additional 34 shares during the period. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Activity

In other news, Director Ronda E. Stryker sold 300,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the sale, the director owned 2,301,375 shares of the company’s stock, valued at approximately $773,031,862.50. The trade was a 11.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Dylan Crotty sold 441 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the sale, the insider owned 6,102 shares of the company’s stock, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 351,267 shares of company stock valued at $118,197,701. 4.60% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Citigroup reaffirmed a “market outperform” rating on shares of Stryker in a report on Friday, October 30th. BTIG Research lowered their price objective on Stryker from $316.00 to $304.00 and set a “buy” rating on the stock in a research report on Friday, October 30th. Rothschild & Co Redburn dropped their price objective on Stryker from $360.00 to $336.00 in a research note on Monday, November 2nd. Evercore boosted their target price on Stryker from $335.00 to $355.00 in a research report on Wednesday, October 28th. Finally, The Goldman Sachs Group decreased their target price on Stryker from $363.00 to $339.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 14th. Twenty-one analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $343.73.

View Our Latest Stock Report on SYK

Stryker Price Performance

Shares of Stryker stock opened at $325.26 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.30 and a current ratio of 2.18. Stryker Corporation has a 52-week low of $267.00 and a 52-week high of $389.33. The company has a fifty day moving average of $292.37 and a 200-day moving average of $323.59. The stock has a market capitalization of $123.83 billion, a price-to-earnings ratio of 34.64, a price-to-earnings-growth ratio of 2.24 and a beta of 0.78.

Stryker (NYSE:SYK – Get Free Report) last issued its earnings results on Thursday, October 29th. The medical technology company reported $3.52 EPS for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). The business had revenue of $6.52 billion during the quarter, compared to analysts’ expectations of $6.62 billion. Stryker had a return on equity of 23.74% and a net margin of 13.78%. Stryker’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.19 EPS. Equities research analysts expect that Stryker Corporation will post 14.84 EPS for the current year.

Stryker Profile

(Free Report)

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings.

The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Founded in 1941 by orthopedic surgeon Dr.